Prognostic impact of CD133 expression in gastric carcinoma

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2453-2457

  Ishigami, Sumiya ^a   Ueno, Shinichi ^a   Arigami, Takaaki ^a   Uchikado, Yasuto ^a   Setoyama, Tetsuro ^a   Arima, Hideo ^a   Kita, Yoshiaki ^a   Kurahara, Hiroshi ^a   Okumura, Hiroshi ^a   Matsumoto, Masataka ^a   Kijima, Yuko ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

CD133; Gastric cancer; Prognosis; Stem cell

Indexed keywords

CD133 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER STEM CELL; CANCER SURGERY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOLOGICAL MARKERS; GLYCOPROTEINS; HUMANS; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS; STOMACH NEOPLASMS;

EID: 77955073877     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jordan CT, Guzman ML and Noble M: Cancer stem cells. N Engl J Med 355: 1253-1261, 2006.
2. Kim CF and Dirks PB: Cancer and stem cell biology: how tightly intertwined? Cell Stem Cell 3: 147-150, 2008.
3. Huff CA and Matsui W: Multiple myeloma cancer stem cells. J Clin Oncol 26: 2895-2900, 2008.
4. Dell'Albani P: Stem cell markers in gliomas. Neurochem Res 33: 2407-2415, 2008.
5. Simeone DM: Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer. Clin Cancer Res 14: 5646-5648, 2008.
6. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY and Wang XW: EpCAM-positive hepatocellular carcinoma cells are rumor-initiating cells with stem/progenitor cell features. Gastroenterology 136: 1012-1024, 2009.
7. Kojima M, Ishii G, Atsumi N, Fujii S, Saito N and Ochiai A: Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. Cancer Sci 99: 1578-1583, 2008.
8. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM and Isaacs JT: The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 68: 9703-9711, 2008.
9. + hematopoietic stem cells. Ann NY Acad Sci 996: 141-151, 2003. (Pubitemid 36706596)
10. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P and Deliliers GL: Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 115: 186-194, 2001. (Pubitemid 32995115)
11. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
12. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma -2nd English Edition. Gastric Cancer 1: 10-24, 1998.
13. Horst D, Kriegl L, Engel J, Kirchner T and Jung A: CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Brit J Cancer 99: 1285-1289, 2008.
14. Song W, Li H, Tao K, Li R, Song Z, Zhao Q, Zhang F and Dou K: Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract 62: 1212-1218, 2008.
15. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B and Herold-Mende CC: Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14: 123-129, 2008.
16. Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T and Takao S: CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 98: 1389-1397, 2008.
17. Maitland NJ and Collins AT: Prostate cancer stem cells: a new target for therapy. J Clin Oncol 26: 2862-2870, 2008.
18. Donnenberg VS and Donnenberg AD: Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol 45: 872-277, 2005.
19. Ishii H, Iwatsuki M, Ieta K, Ohta D, Haraguchi N, Mimori K and Mori M: Cancer stem cells and chemoradiation resistance. Cancer Sci 99: 1871-1877, 2008.
20. Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Gerber HP, Van Orden KL, Moore PA, Ruben SM and Carter PJ: CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer 99: 100-109, 2008.